Copyright Reports & Markets. All rights reserved.

Global COVID-19 Medicine Market Growth (Status and Outlook) 2020-2025

Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Research Objectives
  • 1.3 Years Considered
  • 1.4 Market Research Methodology
  • 1.5 Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 What is the Impact of Covid-19 Outbreak On the COVID-19 Medicine?
  • 1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
  • 1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
  • 1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global COVID-19 Medicine Market Size in 2020, by Scenario
  • 1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
  • 2 Executive Summary

    • 2.1 World Market Overview
    • 2.1.1 Global COVID-19 Medicine Market Size 2021-2025
  • 2.1.2 COVID-19 Medicine Market Size CAGR by Region
  • 2.2 COVID-19 Medicine Segment by Type
  • 2.2.1 Tablet
  • 2.2.2 Injection
  • 2.3 COVID-19 Medicine Market Size by Type
  • 2.3.1 Global COVID-19 Medicine Market Size Market Share by Type (2021-2025)
  • 2.3.2 Global COVID-19 Medicine Market Size Growth Rate by Type (2021-2025)
  • 2.4 COVID-19 Medicine Segment by Application
  • 2.4.1 Patients With Mild Symptoms
  • 2.4.2 Critically Ill
  • 2.4.3 Other
  • 2.5 COVID-19 Medicine Market Size by Application
  • 2.5.1 Global COVID-19 Medicine Market Size Market Share by Application (2021-2025)
  • 2.5.2 Global COVID-19 Medicine Market Size Growth Rate by Application (2021-2025)
  • 3 COVID-19 Medicine Key Players

    • 3.1 Date of Key Players Enter into COVID-19 Medicine
    • 3.2 Key Players COVID-19 Medicine Product Offered
    • 3.3 Key Players COVID-19 Medicine Funding/Investment Analysis
    • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
  • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players COVID-19 Medicine Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions
  • 4 COVID-19 Medicine by Regions

    • 4.1 COVID-19 Medicine Market Size by Regions (2015-2020)
    • 4.2 Americas COVID-19 Medicine Market Size Growth (2015-2020)
    • 4.3 APAC COVID-19 Medicine Market Size Growth (2015-2020)
    • 4.4 Europe COVID-19 Medicine Market Size Growth (2015-2020)

    5 Americas

    • 5.1 Americas COVID-19 Medicine Market Size by Countries (2021-2025)
    • 5.2 Americas COVID-19 Medicine Market Size by Type (2021-2025)
    • 5.3 Americas COVID-19 Medicine Market Size by Application (2021-2025)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
    • 5.8 Key Economic Indicators of Few Americas Countries

    6 APAC

    • 6.1 APAC COVID-19 Medicine Market Size by Regions
    • 6.2 APAC COVID-19 Medicine Market Size by Type (2021-2025)
    • 6.3 APAC COVID-19 Medicine Market Size by Application (2021-2025)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 Key Economic Indicators of Few APAC Regions

    7 Europe

    • 7.1 Europe COVID-19 Medicine by Countries (2021-2025)
    • 7.2 Europe COVID-19 Medicine Market Size by Type (2021-2025)
    • 7.3 Europe COVID-19 Medicine Market Size by Application (2021-2025)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Key Economic Indicators of Few Europe Countries

    8 Market Drivers, Challenges and Trends

    • 8.1 Market Drivers and Impact
    • 8.1.1 Growing Demand from Key Regions
  • 8.1.2 Growing Demand from Key Applications and Potential Industries
  • 8.2 Market Challenges and Impact
  • 8.3 Market Trends
  • 8.4 Market Ecosystem and Roles
  • 9 Key Investors in COVID-19 Medicine

    • 9.1 Company A
    • 9.1.1 Company A Company Details
  • 9.1.2 Company Description
  • 9.1.3 Companies Invested by Company A
  • 9.1.4 Company A Key Development and Market Layout
  • 9.2 Company B
  • 9.2.1 Company B Company Details
  • 9.2.2 Company Description
  • 9.2.3 Companies Invested by Company B
  • 9.2.4 Company B Key Development and Market Layout
  • 9.3 Company C
  • 9.3.1 Company C Company Details
  • 9.3.2 Company Description
  • 9.3.3 Companies Invested by Company C
  • 9.3.4 Company C Key Development and Market Layout
  • 9.4 Company D
  • 9.5 ……
  • 10 Key Players Analysis

    • 10.1 Advanz Pharma
    • 10.1.1 Advanz Pharma Company Information
  • 10.1.2 COVID-19 Medicine Product Offered
  • 10.1.3 Advanz Pharma COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.1.4 Main Business Overview
  • 10.1.5 Advanz Pharma Latest Developments
  • 10.2 Sichuan Sunny Hope
  • 10.2.1 Sichuan Sunny Hope Company Information
  • 10.2.2 COVID-19 Medicine Product Offered
  • 10.2.3 Sichuan Sunny Hope COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.2.4 Main Business Overview
  • 10.2.5 Sichuan Sunny Hope Latest Developments
  • 10.3 Kyung Poong
  • 10.3.1 Kyung Poong Company Information
  • 10.3.2 COVID-19 Medicine Product Offered
  • 10.3.3 Kyung Poong COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.3.4 Main Business Overview
  • 10.3.5 Kyung Poong Latest Developments
  • 10.4 Novartis
  • 10.4.1 Novartis Company Information
  • 10.4.2 COVID-19 Medicine Product Offered
  • 10.4.3 Novartis COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.4.4 Main Business Overview
  • 10.4.5 Novartis Latest Developments
  • 10.5 Sanofi
  • 10.5.1 Sanofi Company Information
  • 10.5.2 COVID-19 Medicine Product Offered
  • 10.5.3 Sanofi COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.5.4 Main Business Overview
  • 10.5.5 Sanofi Latest Developments
  • 10.6 Mylan
  • 10.6.1 Mylan Company Information
  • 10.6.2 COVID-19 Medicine Product Offered
  • 10.6.3 Mylan COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.6.4 Main Business Overview
  • 10.6.5 Mylan Latest Developments
  • 10.7 Guangzhou Baiyunshan Guanghua Pharmaceutical
  • 10.7.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  • 10.7.2 COVID-19 Medicine Product Offered
  • 10.7.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.7.4 Main Business Overview
  • 10.7.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Latest Developments
  • 10.8 Apotex
  • 10.8.1 Apotex Company Information
  • 10.8.2 COVID-19 Medicine Product Offered
  • 10.8.3 Apotex COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.8.4 Main Business Overview
  • 10.8.5 Apotex Latest Developments
  • 10.9 Ipca Laboratories
  • 10.9.1 Ipca Laboratories Company Information
  • 10.9.2 COVID-19 Medicine Product Offered
  • 10.9.3 Ipca Laboratories COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.9.4 Main Business Overview
  • 10.9.5 Ipca Laboratories Latest Developments
  • 10.10 Bayer
  • 10.10.1 Bayer Company Information
  • 10.10.2 COVID-19 Medicine Product Offered
  • 10.10.3 Bayer COVID-19 Medicine Market Size (2020 VS 2025)
  • 10.10.4 Main Business Overview
  • 10.10.5 Bayer Latest Developments
  • 10.11 Bristol Laboratories
  • 10.12 Shanghai Pharma
  • 10.13 Shanghai Zhongxisanwei
  • 10.14 Zydus Cadila
  • 10.15 Rising Pharmaceutical
  • 10.16 Sun Pharma
  • 10.17 KPC Group
  • 10.18 Teva
  • 11 Research Findings and Conclusion

    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
    According to this latest study, the 2020 growth of COVID-19 Medicine will have significant change from previous year. By the most conservative estimates of global COVID-19 Medicine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the COVID-19 Medicine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.


    This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Medicine market by product type, application, key manufacturers and key regions and countries.


    This study specially analyses the impact of Covid-19 outbreak on the COVID-19 Medicine, covering the supply chain analysis, impact assessment to the COVID-19 Medicine market size growth rate in several scenarios, and the measures to be undertaken by COVID-19 Medicine companies in response to the COVID-19 epidemic.


    Segmentation by product type:


    Tablet


    Injection


    Segmentation by Application:


    Patients With Mild Symptoms


    Critically Ill


    Other


    This report also splits the market by region:


    Americas


    United States


    Canada


    Mexico


    APAC


    China


    Japan


    Korea


    Southeast Asia


    India


    Australia


    Europe


    Germany


    France


    UK


    Italy


    Russia


    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/players in the market. The key players covered in this report:


    Advanz Pharma


    Sichuan Sunny Hope


    Kyung Poong


    Novartis


    Sanofi


    Mylan


    Guangzhou Baiyunshan Guanghua Pharmaceutical


    Apotex


    Ipca Laboratories


    Bayer


    Bristol Laboratories


    Shanghai Pharma


    Shanghai Zhongxisanwei


    Zydus Cadila


    Rising Pharmaceutical


    Sun Pharma


    KPC Group


    Teva


    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.


    Research objectives


    To study and analyze the global COVID-19 Medicine market size by key regions/countries, type and application.


    To understand the structure of COVID-19 Medicine market by identifying its various subsegments.


    Focuses on the key global COVID-19 Medicine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.


    To analyze the COVID-19 Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.


    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).


    To project the size of COVID-19 Medicine submarkets, with respect to key regions (along with their respective key countries).


    To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.


    To strategically profile the key players and comprehensively analyze their growth strategies.

    Buy now